Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders

T cell responses against malignant cells play a major role in maintaining remission and prolonging overall survival in patients after allogeneic stem cell transplantation and donor lymphocyte infusion (DLI) due to graft-versus-leukemia effect. For better characterization of the T cell responses, we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hofmann, Susanne (VerfasserIn) , Schmitt, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2019
In: International journal of cancer
Year: 2019, Jahrgang: 144, Heft: 5, Pages: 1135-1146
ISSN:1097-0215
DOI:10.1002/ijc.31753
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1002/ijc.31753
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31753
Volltext
Verfasserangaben:Susanne Hofmann, Michael Schmitt, Marlies Götz, Hartmut Döhner, Markus Wiesneth, Donald Bunjes and Jochen Greiner

MARC

LEADER 00000caa a2200000 c 4500
001 1587710277
003 DE-627
005 20251112124127.0
007 cr uuu---uuuuu
008 190215s2019 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.31753  |2 doi 
035 |a (DE-627)1587710277 
035 |a (DE-576)517710277 
035 |a (DE-599)BSZ517710277 
035 |a (OCoLC)1341038339 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hofmann, Susanne  |e VerfasserIn  |0 (DE-588)1147869723  |0 (DE-627)1007274824  |0 (DE-576)496081845  |4 aut 
245 1 0 |a Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders  |c Susanne Hofmann, Michael Schmitt, Marlies Götz, Hartmut Döhner, Markus Wiesneth, Donald Bunjes and Jochen Greiner 
264 1 |c 2019 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online 14 Jul 2018 
500 |a Gesehen am 15.02.2019 
520 |a T cell responses against malignant cells play a major role in maintaining remission and prolonging overall survival in patients after allogeneic stem cell transplantation and donor lymphocyte infusion (DLI) due to graft-versus-leukemia effect. For better characterization of the T cell responses, we assessed frequency and diversity of leukemia-associated antigen (LAA)-specific cytotoxic T cells using ELISpot and pMHC multimer assays and analyzed the frequency of regulatory T cells (Treg) as well as cytokine profiles before/after DLI. The data were correlated to the clinical course of patients. Significantly more LAA-derived T cell epitopes (p = 0.02) were recognized in clinical responders (R) when compared to nonresponders (NR). In addition, pMHC multimer-based flow cytometry showed a significantly higher frequency of LAA-specific T cells in R versus NR. The frequency of Treg in R decreased significantly (p = 0.008) while keeping stable in NR. No differences in T cell subset analysis before/after DLI were revealed. Clinical responders were correlated to specific immune responses and all clinical responders showed an increase of specific immune responses after DLI. Cytokine assays using enzyme-linked immunosorbent assay showed a significant increase of IL-4 after DLI. Taken together, an increase of specific CTL responses against several LAA after DLI was detected. Moreover, this study suggests that enhanced LAA diversity in T cell responses as well as decreasing numbers of Treg contribute to clinical outcome of patients treated with DLI. 
650 4 |a cytotoxic T cell responses 
650 4 |a donor lymphocyte infusion 
650 4 |a leukemia-associated-antigens 
700 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 144(2019), 5, Seite 1135-1146  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders 
773 1 8 |g volume:144  |g year:2019  |g number:5  |g pages:1135-1146  |g extent:12  |a Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders 
856 4 0 |u http://dx.doi.org/10.1002/ijc.31753  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31753  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190215 
993 |a Article 
994 |a 2019 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1147869723  |a Hofmann, Susanne  |m 1147869723:Hofmann, Susanne  |d 910000  |d 910100  |e 910000PH1147869723  |e 910100PH1147869723  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1587710277  |e 3056023173 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"12 S."}],"recId":"1587710277","note":["Online 14 Jul 2018","Gesehen am 15.02.2019"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders","title_sort":"Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders"}],"person":[{"display":"Hofmann, Susanne","family":"Hofmann","role":"aut","given":"Susanne"},{"display":"Schmitt, Michael","role":"aut","given":"Michael","family":"Schmitt"}],"relHost":[{"corporate":[{"display":"International Union against Cancer","role":"isb"}],"titleAlt":[{"title":"Predictive oncology"}],"pubHistory":["1.1966 -"],"id":{"eki":["269532781"],"issn":["1097-0215"],"zdb":["1474822-8"],"doi":["10.1002/(ISSN)1097-0215"]},"part":{"issue":"5","extent":"12","text":"144(2019), 5, Seite 1135-1146","pages":"1135-1146","volume":"144","year":"2019"},"origin":[{"publisher":"Wiley-Liss","dateIssuedKey":"1966","publisherPlace":"Bognor Regis","dateIssuedDisp":"1966-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"title":[{"subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title":"International journal of cancer","title_sort":"International journal of cancer"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"269532781","titleTranslated":[{"translated":"Journal international du cancer"}],"disp":"Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical respondersInternational journal of cancer"}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"id":{"eki":["1587710277"],"doi":["10.1002/ijc.31753"]},"name":{"displayForm":["Susanne Hofmann, Michael Schmitt, Marlies Götz, Hartmut Döhner, Markus Wiesneth, Donald Bunjes and Jochen Greiner"]}} 
SRT |a HOFMANNSUSDONORLYMPH2019